Jci_page_head_homepage_01 Jci_page_head_homepage_02
Birgit Liliensiek, Markus A. Weigand, Angelika Bierhaus, Werner Nicklas, Michael Kasper, Stefan Hofer, Jens Plachky, Herman-Josef Gröne, Florian C. Kurschus, Ann Marie Schmidt, Shi Du Yan, Eike Martin, Erwin Schleicher, David M. Stern, Günter J. Hämmerling, Peter P. Nawroth, Bernd Arnold
Published in Volume 113, Issue 11
J Clin Invest. 2004; 113(11):1641–1650 doi:10.1172/JCI18704
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Generation and characterization of the Tie2RAGE mouse line. (A) Tie2RAGE construct. Genomic RAGE DNA was cloned between the Tie2 promoter and enhancer. Gray boxes indicate RAGE exons; Roman numerals indicate RAGE exon numbers. E, EcoRI restriction enzyme site. (B) Southern blot analysis of DNA obtained from tail biopsies from WT and Tie2RAGE mice; EcoRI digestion releases a 2.2-kb DNA fragment from the Tie2RAGE transgene. (C) RT-PCR of different tissues derived from Tie2RAGE (Tie2) and WT mice analyzed for RAGE mRNA expression. WT indicates transgene-negative littermates. HPRT was used to demonstrate equal loading. (D) Immunohistology for RAGE protein in Tie2RAGE and WT kidney tissue. Brown staining indicates RAGE expression; magnification, ∞400. RAGE expression in kidneys of Tie2RAGE mice is evident in the endothelium of large and small vessels, while no RAGE protein could be detected in kidneys of healthy WT mice.